These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 26985072)

  • 1. Management of stage IIIA (N2) non-small-cell lung cancer: a transatlantic perspective†.
    Rocco G; Nason K; Brunelli A; Varela G; Waddell T; Jones DR
    Eur J Cardiothorac Surg; 2016 Apr; 49(4):1025-7. PubMed ID: 26985072
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of stage IIIA (N2) non-small cell lung cancer: A transatlantic perspective.
    Rocco G; Nason K; Brunelli A; Varela G; Waddell T; Jones DR
    J Thorac Cardiovasc Surg; 2016 May; 151(5):1235-8. PubMed ID: 26997100
    [No Abstract]   [Full Text] [Related]  

  • 3. Management of Stage IIIA (N2) Non-Small Cell Lung Cancer: A Transatlantic Perspective.
    Rocco G; Nason K; Brunelli A; Varela G; Waddell T; Jones DR
    Ann Thorac Surg; 2016 Apr; 101(4):1247-50. PubMed ID: 26997577
    [No Abstract]   [Full Text] [Related]  

  • 4. Management algorithms for stage IIIA non-small cell lung cancer with N2 node involvement.
    Detterbeck F; Sukumar MS
    Thorac Surg Clin; 2008 Nov; 18(4):437-41, vii. PubMed ID: 19086612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of Stage IIIA (N2) Non-Small Cell Lung Cancer.
    Gillaspie EA; Wigle DA
    Thorac Surg Clin; 2016 Aug; 26(3):271-85. PubMed ID: 27427522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation and management of patients with stage IIIA (N2) non-small-cell lung cancer.
    Garland L; Robinson LA; Wagner H
    Chest Surg Clin N Am; 2001 Feb; 11(1):69-100, viii. PubMed ID: 11253602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stage IIIA N2 non-small-cell lung cancer: current controversies in combined-modality therapy.
    Thomas PA
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):431-2. PubMed ID: 19524447
    [No Abstract]   [Full Text] [Related]  

  • 8. What is the optimal treatment of stage IIIA-N2 non-small-cell lung cancer after EORTC 08941?
    Van Meerbeeck JP; De Pauw R; Tournoy K
    Expert Rev Anticancer Ther; 2008 Feb; 8(2):199-206. PubMed ID: 18279061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scalpels, beams, drugs, and dreams: challenges of stage IIIA-N2 non-small-cell lung cancer.
    Johnson DH; Rusch VW; Turrisi AT
    J Natl Cancer Inst; 2007 Mar; 99(6):415-8. PubMed ID: 17374824
    [No Abstract]   [Full Text] [Related]  

  • 10. Improved results of induction chemoradiation before surgical intervention for selected patients with stage IIIA-N2 non-small cell lung cancer.
    Uy KL; Darling G; Xu W; Yi QL; De Perrot M; Pierre AF; Waddell TK; Johnston MR; Bezjak A; Shepherd FA; Keshavjee S
    J Thorac Cardiovasc Surg; 2007 Jul; 134(1):188-93. PubMed ID: 17599507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Optimal Local Treatment of Stage IIIA-N2 NSCLC: Is the Issue Finally Settled?
    De Ruysscher D; Vansteenkiste J; Belderbos J; Decaluwé H; Dingemans AM
    J Thorac Oncol; 2016 Mar; 11(3):284-6. PubMed ID: 26922920
    [No Abstract]   [Full Text] [Related]  

  • 12. Stage IIIA-N2 NSCLC: a review of its treatment approaches and future developments.
    van Meerbeeck JP; Surmont VF
    Lung Cancer; 2009 Sep; 65(3):257-67. PubMed ID: 19285751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generalized or personalized treatment for stage IIIA-N2 non-small-cell lung cancer?
    Vansteenkiste J; Van Damme V; Dooms C
    Expert Opin Pharmacother; 2010 Jul; 11(10):1605-9. PubMed ID: 20497093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase III Study of Surgery Versus Definitive Concurrent Chemoradiotherapy Boost in Patients With Resectable Stage IIIA(N2) and Selected IIIB Non-Small-Cell Lung Cancer After Induction Chemotherapy and Concurrent Chemoradiotherapy (ESPATUE).
    Eberhardt WE; Pöttgen C; Gauler TC; Friedel G; Veit S; Heinrich V; Welter S; Budach W; Spengler W; Kimmich M; Fischer B; Schmidberger H; De Ruysscher D; Belka C; Cordes S; Hepp R; Lütke-Brintrup D; Lehmann N; Schuler M; Jöckel KH; Stamatis G; Stuschke M
    J Clin Oncol; 2015 Dec; 33(35):4194-201. PubMed ID: 26527789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged survival in patients with resected non-small cell lung cancer and single-level N2 disease.
    Keller SM; Vangel MG; Wagner H; Schiller JH; Herskovic A; Komaki R; Marks RS; Perry MC; Livingston RB; Johnson DH;
    J Thorac Cardiovasc Surg; 2004 Jul; 128(1):130-7. PubMed ID: 15224032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized trial comparing induction chemotherapy followed by surgery with surgery alone for patients with stage IIIA N2 non-small cell lung cancer (JCOG 9209).
    Nagai K; Tsuchiya R; Mori T; Tada H; Ichinose Y; Koike T; Kato H;
    J Thorac Cardiovasc Surg; 2003 Feb; 125(2):254-60. PubMed ID: 12579093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of clinical stage IIIA primary lung cancers in the National Cancer Database.
    Hancock J; Rosen J; Moreno A; Kim AW; Detterbeck FC; Boffa DJ
    Ann Thorac Surg; 2014 Aug; 98(2):424-32; discussion 432. PubMed ID: 24929895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial.
    Pless M; Stupp R; Ris HB; Stahel RA; Weder W; Thierstein S; Gerard MA; Xyrafas A; Früh M; Cathomas R; Zippelius A; Roth A; Bijelovic M; Ochsenbein A; Meier UR; Mamot C; Rauch D; Gautschi O; Betticher DC; Mirimanoff RO; Peters S;
    Lancet; 2015 Sep; 386(9998):1049-56. PubMed ID: 26275735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restaging patients with N2 (stage IIIa) non-small cell lung cancer after neoadjuvant chemoradiotherapy: a closer look at redo mediastinoscopy.
    Granone P; Van Schil P; Cesario A
    J Thorac Cardiovasc Surg; 2007 Jan; 133(1):275-6; author reply 276-7. PubMed ID: 17198837
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of stage IIIA-N2 non-small-cell lung cancer: "Above All, Do No Harm".
    Kernstine KH
    Clin Lung Cancer; 2008 Jul; 9(4):192-3. PubMed ID: 18650164
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.